openPR Logo
Press release

Global Biopreservation Market to grow at a CAGR of 9.15% to reach USD 5,524.33 million by 2032, Evaluates DelveInsight

10-30-2025 08:59 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Biopreservation Market to grow at a CAGR of 9.15% to reach

According to DelveInsight's analysis, The growing incidence of chronic diseases and cancer has heightened the demand for biopreservation, which plays a crucial role in supporting research, diagnostics, and therapeutic advancements. Worldwide, biobanks are expanding to store diverse biological materials such as tissues, stem cells, and DNA, enabling progress in clinical trials and biomedical research. Additionally, increasing awareness about stem cell banking and its potential use in treating future medical conditions is encouraging more individuals to preserve cord blood and other regenerative biological materials.

DelveInsight's "Biopreservation Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Biopreservation companies actively working in the market.

To know more about why North America is leading the market growth in the Biopreservation market, get a snapshot of the report Biopreservation Market Trends
https://www.delveinsight.com/sample-request/biopreservation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Biopreservation Overview
Biopreservation is the process of preserving biological materials such as cells, tissues, organs, or genetic material at controlled temperatures to maintain their viability, functionality, and integrity for future use. It involves techniques like cryopreservation (freezing), hypothermic storage, and vitrification to slow down or halt biological degradation. Biopreservation is essential in areas such as regenerative medicine, cell therapy, organ transplantation, reproductive medicine, and biobanking, ensuring that biological samples remain stable and effective for research, diagnostics, or therapeutic applications.

DelveInsight Analysis: The biopreservation market size was valued at USD 2,755.43 million in 2024 and is expected to grow at a CAGR of 9.15% from 2025 to 2032, reaching approximately USD 5,524.33 million by 2032.

Biopreservation Market Insights
Geographically, North America is expected to dominate the biopreservation market, holding the largest share globally. This leadership is attributed to its advanced healthcare infrastructure, high burden of chronic diseases and cancer, and substantial investments in biobanking and regenerative medicine. The strong presence of leading market players further reinforces the region's position. Moreover, growing awareness of stem cell banking, supportive government initiatives for cutting-edge research, and an increasing number of clinical trials in cell-based therapies are driving market expansion. Additionally, the region's focus on personalized medicine, along with progress in organ transplantation and immunotherapy, continues to boost the demand for biopreservation technologies.

To read more about the latest highlights related to Biopreservation, get a snapshot of the key highlights entailed in the Biopreservation Market Insights
https://www.delveinsight.com/report-store/biopreservation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Biopreservation Market Report
• In November 2023, BioLife Solutions announced that it has raised USD 10.4 million through private placement by Casdin Capital to support ongoing operations related to biopreservation media and other offerings.
• In February 2022, OriGen received CE mark approval for the CryoStoreTM FLEX Freezing Bag product line. Additionally, the company announced the global launch of the CryoStoreTM FLEX freezing bag.
• In June 2023, SCTbio collaborated with Cyto-carein to improve the quality of cryopreservation for cell therapy manufacturing development in Europe.
• Thus, owing to such developments in the market, rapid growth will be observed in the Biopreservation market during the forecast period

Key Players in the Biopreservation Market
Some of the key market players operating in the Biopreservation market include- BioLife Solutions, Cell Applications, HiMedia Laboratories, Merck KGaA, Thermo Fisher Scientific, United States Biological, ZenBio, OriGen, SCTbio, Azenta US, Inc., LabVantage Solutions Inc., Hamad Medical Corporation, OriGen Biomedical, STEMCELL Technologies, Cryoport, Inc. and others.

Which MedTech key players in the Biopreservation market are set to emerge as the trendsetter explore @ Key Biopreservation Companies
https://www.delveinsight.com/sample-request/biopreservation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Biopreservation Market Landscape
Biopreserved materials are extremely sensitive to temperature variations, requiring precise monitoring and specialized cold chain logistics to maintain their integrity. Even minor deviations from ideal storage conditions can cause sample deterioration, affecting both research quality and therapeutic effectiveness. Furthermore, adhering to strict regulatory standards, such as current Good Manufacturing Practices (cGMP) set by the FDA and EMA, poses operational challenges that may slow market expansion.
Despite these hurdles, the combined influence of increasing cancer cases, expanding biobank networks, rising awareness of stem cell preservation, and ongoing technological innovations is expected to propel substantial growth in the global biopreservation market between 2025 and 2032.

Scope of the Biopreservation Market Report
• Coverage: Global
• Study Period: 2022-2032
• Biopreservation Market Segmentation By Type: Anthropomorphic Phantoms and Calibration Phantoms)
• Biopreservation Market Segmentation By Imaging Modalities: X-ray, CT, Mammography, MRI, and Others
• Biopreservation Market Segmentation By Application: Quality Control, Equipment Calibration, Dosimetry, and Others
• Biopreservation Market Segmentation By End-User: Hospitals and Clinics, Diagnostic Centers, Academic and Research Institutes, Medical Device Companies, and Others
• Biopreservation Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Biopreservation Companies: BioLife Solutions, Cell Applications, HiMedia Laboratories, Merck KGaA, Thermo Fisher Scientific, United States Biological, ZenBio, OriGen, SCTbio, Azenta US, Inc., LabVantage Solutions Inc., Hamad Medical Corporation, OriGen Biomedical, STEMCELL Technologies, Cryoport, Inc. and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Biopreservation market will grow by 2032? Click to get a snapshot of the Biopreservation Market Analysis
https://www.delveinsight.com/sample-request/biopreservation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biopreservation Market to grow at a CAGR of 9.15% to reach USD 5,524.33 million by 2032, Evaluates DelveInsight here

News-ID: 4247493 • Views:

More Releases from DelveInsight Business Research

Retinitis Pigmentosa Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight
Retinitis Pigmentosa Pipeline 2026: FDA Approvals and Clinical Trials Landscape …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Retinitis Pigmentosa pipeline constitutes 20+ key companies continuously working towards developing 25+ Retinitis Pigmentosa treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Retinitis Pigmentosa Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Retinitis Pigmentosa Market. The Retinitis
Multiple Sclerosis Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight
Multiple Sclerosis Pipeline 2026: Therapies, MOA Insights, and Key Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Sclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Multiple Sclerosis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also
Car T Cell Therapy For Multiple Myeloma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight
Car T Cell Therapy For Multiple Myeloma Pipeline 2026: MOA, ROA, FDA-Approved Dr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Car T Cell Therapy For Multiple Myeloma pipeline constitutes 5+ key companies continuously working towards developing 5+ Car T Cell Therapy For Multiple Myeloma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Car T Cell Therapy For Multiple Myeloma Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into
Spinocerebellar Ataxias Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight
Spinocerebellar Ataxias Pipeline 2026: Therapies Under Investigation, Clinical T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Spinocerebellar Ataxias Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market. The Spinocerebellar

All 5 Releases


More Releases for Biopreservation

Evolving Market Trends In The Biopreservation Market Industry: Next-Generation T …
The Biopreservation Market Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Biopreservation Market Market Size During the Forecast Period? The Biopreservation Market Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This
Key Trend Reshaping the Biopreservation Market Market in 2025: Next-Generation T …
What combination of drivers is leading to accelerated growth in the biopreservation market market? The boom in demand for customized medical treatments is positively impacting the expansion of the biopreservation market. This kind of medical care is employed to combat illnesses that are unique to individual patients. Biobanks aid in the creation of these personalized medications by allowing for the biopreservation of human cells and tissue. As an illustration, in February
Biopreservation Refrigerator Market Size 2024 to 2031.
Market Overview and Report Coverage A biopreservation refrigerator is a specialized type of refrigerator that is designed to store biological samples at low temperatures to ensure their viability for future use. These refrigerators are commonly used in laboratories, hospitals, and research facilities to preserve samples such as vaccines, blood, tissues, and other biological materials. The future outlook for the biopreservation refrigerator market is promising, with a projected growth rate of
Biopreservation Market - Driving Advances in Biopreservation Technology: Redefin …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Biopreservation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Biopreservation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical
Biopreservation Refrigerator Market 2022 | Detailed Report
According to Market Study Report, Biopreservation Refrigerator Market provides a comprehensive analysis of the Biopreservation Refrigerator Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5495258 The report provides a comprehensive analysis of company profiles listed below: - Thermo Fisher Scientific Inc. - Merck KGaA -
02-03-2017 | Health & Medicine
TMR
Global Biopreservation Market Shifts to High Gear with Improvements in Biopreser …
This report encompasses market estimations for the global biopreservation market for the forecast period 2013 to 2019. The market size is forecast considering 2012 as the base year and is represented in terms of USD million. The stakeholders for this report include market players in the biopreservation industry who aspire to gain further insights into this market in terms of different product types and applications. Moreover, this report can also